Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2005
10/27/2005US20050239163 Cloning, expression and functional characterization of a mammalian DNA-R gene; polypetide having amino acid sequence with deletion at 1133 1171 amino acids
10/27/2005US20050239161 Genetic strain optimization for improving the production of riboflavin
10/27/2005US20050239159 Gtp cyclohydrolase II as as target for fungicides
10/27/2005US20050239141 Modified antibody variable domains
10/27/2005US20050239134 Combinatorial selection of phosphorothioate single-stranded DNA aptamers for TGF-beta-1 protein
10/27/2005US20050239128 Using calibrators, primers, probes and nucleic acid polymerase
10/27/2005US20050239126 Proteases
10/27/2005US20050239124 Modulation of STAT 6 expression
10/27/2005US20050239121 Non-aggregating non-quenching oligomers comprising nucleotide analogs; methods of synthesis and use thereof
10/27/2005US20050239120 Bio molecular detection apparatus and method thereof
10/27/2005US20050239119 PCR amplification reaction apparatus and method for PCR amplification reaction using apparatus
10/27/2005US20050239118 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1
10/27/2005US20050239110 Method of diagnosing depression
10/27/2005US20050239105 NOD2 nucleic acids and proteins
10/27/2005US20050239103 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/27/2005US20050239099 27 human secreted proteins
10/27/2005US20050239094 Compositions and methods for inducing and regulating bone formation
10/27/2005US20050239091 Extraction of nucleic acids using small diameter magnetically-responsive particles
10/27/2005US20050239088 Intron fusion proteins, and methods of identifying and using same
10/27/2005US20050239084 Probes and methods for detection of nucleic acids
10/27/2005US20050239081 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, isolated PEF protein, and methods for purifying and identifying
10/27/2005US20050239080 Mismatch repair detection
10/27/2005US20050239074 Hansenula polymorpha yapsin deficient mutant strain and process for the preparation of recombinant proteins using the same
10/27/2005US20050239071 Genetic testing
10/27/2005US20050239069 which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells; gene therapy
10/27/2005US20050239068 Method for isolating nucleic acids and protein from a single sample
10/27/2005US20050239067 Method of detecting and quantifying hemolysin-producing bacteria by overwhelmingly detecting and quantifying thermostable hemolysin-related genes (tdh-related hemolysin genes) of food poisoning bacteria
10/27/2005US20050239065 Formed by splicing, genetic deletions, point mutations; vectors; host cells
10/27/2005US20050239064 Methods and compositions based on protein interactions with mastermind
10/27/2005US20050239061 Identification and use of effectors and allosteric molecules for the alteration of gene expression
10/27/2005US20050239052 Cloning of rhadinovirus genome and methods for its use
10/27/2005US20050239051 Use of isogenic human cancer cells for high-throughput screening and drug discovery
10/27/2005US20050239043 Subtilisin carlsberg proteins with reduced immunogenicity
10/27/2005US20050239040 System for producing mammalian pre-embryo and stem cell having better quality; co-culturing of oocytes and spermatozoa in lowered oxygen tension
10/27/2005US20050238723 Method of producing hydroxyalkyl starch derivatives
10/27/2005US20050238658 Transposon
10/27/2005US20050238657 Defective entities and uses therefor
10/27/2005US20050238656 Recombinant vesiculoviruses and their uses
10/27/2005US20050238652 Human lung adenocarcinoma-related monoclonal antibody and antigen and immunaossay method which uses the same
10/27/2005US20050238642 Modified bouganin proteins, cytotoxins and methods and uses thereof
10/27/2005US20050238637 Vectors for molecule delivery to CD11b expressing cells
10/27/2005US20050238629 Vector capable of transduction non-dividing or slowly diviving cell; gene expression in protein; genetic engineering
10/27/2005US20050238624 Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications
10/27/2005US20050238622 Compositions and methods for treating cancer with an oncolytic viral agent
10/27/2005US20050238607 FGF-5 supported and binding peptides
10/27/2005US20050238606 Enhance delivery of oligonucleotides, nucleosides, nucleic acids by injection or applying on skin water solution of nucleic acid for delivery to hair follicles to inhibit hair growth
10/27/2005US20050238579 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
10/27/2005US20050238534 Apparatus and methods for efficient processing of biological samples on slides
10/27/2005DE19964269B4 Verfahren zur Detektion des Proliferationspotentials von Zellen A process for the detection of the proliferation potential of cells
10/27/2005DE102004017518A1 Preparing unsaturated fatty acid derivatives, for use e.g. as pharmaceuticals and cosmetics, in seeds of transgenic plants, comprises growing plants that contain specific elongase and desaturase genes
10/27/2005DE102004017370A1 PUFA-PKS Gene aus Ulkenia PUFA-PKS genes from Ulkenia
10/27/2005CA2838451A1 Methods for degrading or converting plant cell wall polysaccharides
10/27/2005CA2770521A1 Tape stripping methods for analysis of skin disease and pathological skin state
10/27/2005CA2564119A1 Methods of obtaining optically active epoxides and vicinal diols from styrene oxides
10/27/2005CA2563578A1 Diagnostic and therapeutic applications of soluble lhcgr protein
10/27/2005CA2563469A1 Method and dna constructs for increasing the production level of carbohydrate degrading enzymes in filamentous fungi
10/27/2005CA2563407A1 Methods for identifying genes that mediate a response of a living cell to an agent
10/27/2005CA2563388A1 Microrna and methods for inhibiting same
10/27/2005CA2563332A1 Therapeutic uspa1-derived peptides
10/27/2005CA2563295A1 Antibodies to erythropoietin receptor and uses thereof
10/27/2005CA2563266A1 Kluyveromyces lactis promoter variants lacking e. coli transcriptional capability
10/27/2005CA2562892A1 Bob-1 specific t cells and methods to use
10/27/2005CA2562885A1 Follistatin variant polypeptide
10/27/2005CA2562881A1 Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103
10/27/2005CA2562830A1 Replication competent viruses capable of silencing virus inhibitory factor expression
10/27/2005CA2562761A1 Expression system for preparing il-15/fc fusion proteins and its use
10/27/2005CA2561742A1 Methods for identifying risk of osteoarthritis and treatments thereof
10/27/2005CA2561714A1 Methods and compositions for treating neuropathic and neurodegenerative conditions
10/27/2005CA2561533A1 Anti-p-selectin antibodies
10/27/2005CA2561325A1 Compositions and methods for reverse transcription
10/27/2005CA2560205A1 Fungal promoters for expressing a gene in a fungal cell
10/27/2005CA2559368A1 Method for purifying plasmid dna
10/27/2005CA2554209A1 Cell display libraries
10/27/2005CA2553684A1 Biosensor based on directed assembly of particles
10/26/2005EP1589116A2 Use of an extraction control in a method of extracting nucleic acids
10/26/2005EP1589115A2 Polymorphisms of the human organic anion transporting polypeptide-C (OATP-C)
10/26/2005EP1589114A2 Compositions and methods for the detection of chlamydia trachomatis
10/26/2005EP1589111A1 Recombinant hepatitis a virus antigens obtained in plant cells
10/26/2005EP1589110A1 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid
10/26/2005EP1589109A2 VMP-like sequences of pathogenic borrelia
10/26/2005EP1589108A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
10/26/2005EP1589107A1 Immunoglobulins devoid of light chains
10/26/2005EP1589106A1 Adiponectin receptor and gene coding for the same
10/26/2005EP1589105A1 Extraction of nucleic acids using small diameter magnetically-responsive particles
10/26/2005EP1589103A1 Method of screening agent for improving memory and learning ability
10/26/2005EP1589102A1 Gene sequence of l-rhamnose isomerase having new catalytic function and use thereof
10/26/2005EP1589100A1 Transcriptional activator
10/26/2005EP1589099A1 Immortalized natural killer cell line
10/26/2005EP1589096A1 Method for producing L-amino acid
10/26/2005EP1589034A2 Rationally designed antibodies
10/26/2005EP1589032A1 Genetically-modified yeasts which can float in a liquid medium, production method thereof and use of same
10/26/2005EP1589031A2 Production of polyketides and other natural products
10/26/2005EP1589028A2 Modified oligonucleotides, their preparation and their use
10/26/2005EP1589025A2 Nucleic acid labeling compounds
10/26/2005EP1588761A2 Combinatorial strategies for polymer synthesis
10/26/2005EP1588755A1 Target detecting device and target capturer, molecule adsorption/desorption device and molecule adsoprtion/desoption method, and protein detecting device and protein detecting method
10/26/2005EP1588718A1 Gene therapy of hepatocyte growth factor to enhance muscular and cutaneous flap survival
10/26/2005EP1588713A1 Production of human papillomavirus HBV-11 capsid protein L1 and virus-like particles
10/26/2005EP1588712A1 Modulators of regulatory proteins
10/26/2005EP1588616A2 Method of transporting transgenic Xenopus laevis oocytes